Inflation Is Rising Again. History Says These 2 Stocks Are Among the Smartest Places to Hide
Inflation affects corporations differently. These two have the tools to navigate the challenge better than most.
Inflation rates rose again in 2026, primarily due to escalating energy and oil costs. However, this trend has softened slightly over the last fortnight. Despite this, there remains uncertainty about future developments. Inflation could surge significantly once more if international disputes continue. Investors should brace for this possibility and one strategy is to acquire shares in firms that have traditionally thrived during periods of high inflation.
Two companies that fit this description are Vertex Pharmaceuticals (NASDAQ: VRTX) and Visa (NYSE: V). Let's explore the reasons why these businesses are attractive investments at present. Image source: The Motley Fool. Vertex Pharmaceuticals, a prominent biotechnology firm, offers products that are in high demand irrespective of the economic climate.
Nevertheless, unlike many of its competitors, the pharmaceutical company holds a near monopoly in its primary therapeutic area. Vertex Pharmaceuticals markets the exclusive medications targeting the root causes of cystic fibrosis (CF), a rare condition where thick, sticky mucus builds up in the lungs, resulting in breathing difficulties.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
